Boehringer Ingelheim Pharma GmbH & Co. KG secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tiotropium olodaterol ATC R03AL06 for the period 01062024 - 31052026

Germany, June 1 -- Germany based Boehringer Ingelheim Pharma GmbH & Co. KG has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient tiotropium olodaterol ATC R03AL06 for the period 01062024 - 31052026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....